| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| p300-CBP Transcription Factors | 37 | 2021 | 147 | 5.150 |
Why?
|
| Histones | 42 | 2024 | 2591 | 4.370 |
Why?
|
| PTEN Phosphohydrolase | 11 | 2023 | 1117 | 3.800 |
Why?
|
| Histone Demethylases | 18 | 2024 | 328 | 3.520 |
Why?
|
| Lysine | 21 | 2024 | 994 | 3.350 |
Why?
|
| Nucleosomes | 13 | 2024 | 492 | 3.140 |
Why?
|
| Ubiquitin-Protein Ligases | 9 | 2024 | 1897 | 2.990 |
Why?
|
| Enzyme Inhibitors | 35 | 2024 | 3722 | 2.910 |
Why?
|
| Histone Acetyltransferases | 31 | 2024 | 332 | 2.880 |
Why?
|
| Acetylation | 53 | 2024 | 1054 | 2.770 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 6 | 2024 | 146 | 2.330 |
Why?
|
| E1A-Associated p300 Protein | 15 | 2024 | 124 | 2.170 |
Why?
|
| Enzyme Assays | 5 | 2018 | 103 | 2.170 |
Why?
|
| Phosphorylation | 56 | 2024 | 8292 | 2.160 |
Why?
|
| Histone Deacetylases | 11 | 2022 | 713 | 2.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 8 | 2022 | 2455 | 2.130 |
Why?
|
| Acetyltransferases | 18 | 2023 | 230 | 1.900 |
Why?
|
| Protein Processing, Post-Translational | 18 | 2024 | 1962 | 1.820 |
Why?
|
| Models, Molecular | 47 | 2024 | 5382 | 1.790 |
Why?
|
| Protein-Tyrosine Kinases | 19 | 2015 | 2425 | 1.740 |
Why?
|
| Arylamine N-Acetyltransferase | 11 | 2003 | 87 | 1.740 |
Why?
|
| Tyrosine | 13 | 2018 | 1427 | 1.660 |
Why?
|
| Catalysis | 26 | 2023 | 767 | 1.600 |
Why?
|
| Arylalkylamine N-Acetyltransferase | 9 | 2024 | 13 | 1.570 |
Why?
|
| Acyltransferases | 5 | 2015 | 305 | 1.550 |
Why?
|
| Esters | 4 | 2021 | 213 | 1.540 |
Why?
|
| Succinimides | 3 | 2021 | 83 | 1.510 |
Why?
|
| Catalytic Domain | 16 | 2019 | 698 | 1.460 |
Why?
|
| Ubiquitination | 14 | 2024 | 1000 | 1.410 |
Why?
|
| Ubiquitin | 8 | 2024 | 840 | 1.400 |
Why?
|
| Sirtuins | 3 | 2023 | 323 | 1.370 |
Why?
|
| Co-Repressor Proteins | 6 | 2024 | 190 | 1.270 |
Why?
|
| Ghrelin | 5 | 2015 | 255 | 1.270 |
Why?
|
| Protein Kinases | 8 | 2014 | 1611 | 1.260 |
Why?
|
| Protein Engineering | 6 | 2024 | 550 | 1.250 |
Why?
|
| Histone Deacetylase Inhibitors | 9 | 2022 | 778 | 1.210 |
Why?
|
| Coenzyme A | 10 | 2014 | 39 | 1.210 |
Why?
|
| Substrate Specificity | 31 | 2019 | 1751 | 1.200 |
Why?
|
| Structure-Activity Relationship | 23 | 2024 | 3051 | 1.200 |
Why?
|
| src-Family Kinases | 19 | 2012 | 539 | 1.190 |
Why?
|
| Subtilisins | 2 | 2019 | 80 | 1.180 |
Why?
|
| Peptide Synthases | 2 | 2019 | 81 | 1.180 |
Why?
|
| Amino Acid Sequence | 48 | 2020 | 13400 | 1.160 |
Why?
|
| Kinetics | 41 | 2024 | 6273 | 1.150 |
Why?
|
| Enzymes | 3 | 2019 | 253 | 1.140 |
Why?
|
| Peptides | 25 | 2020 | 4338 | 1.130 |
Why?
|
| Recombinant Proteins | 20 | 2020 | 6493 | 1.120 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 7 | 2007 | 147 | 1.120 |
Why?
|
| Crystallography, X-Ray | 23 | 2024 | 1947 | 1.080 |
Why?
|
| Proteins | 18 | 2022 | 5995 | 1.060 |
Why?
|
| Protein Binding | 38 | 2024 | 9301 | 1.010 |
Why?
|
| Histone Deacetylase 1 | 6 | 2021 | 133 | 0.990 |
Why?
|
| Chromatin | 19 | 2024 | 2981 | 0.980 |
Why?
|
| Mutagenesis, Site-Directed | 14 | 2017 | 1677 | 0.970 |
Why?
|
| Molecular Structure | 18 | 2024 | 1881 | 0.940 |
Why?
|
| Biocatalysis | 5 | 2020 | 167 | 0.920 |
Why?
|
| Aminoacyltransferases | 1 | 2024 | 52 | 0.910 |
Why?
|
| Sirtuin 2 | 1 | 2024 | 93 | 0.910 |
Why?
|
| Cysteine Endopeptidases | 2 | 2024 | 542 | 0.900 |
Why?
|
| Cell Cycle Proteins | 15 | 2022 | 3436 | 0.870 |
Why?
|
| Cysteine | 9 | 2020 | 898 | 0.850 |
Why?
|
| Protein Conformation | 22 | 2020 | 3946 | 0.840 |
Why?
|
| Protein Tyrosine Phosphatases | 7 | 2006 | 457 | 0.830 |
Why?
|
| Serine | 4 | 2018 | 828 | 0.830 |
Why?
|
| Molecular Sequence Data | 41 | 2014 | 17597 | 0.820 |
Why?
|
| DNA Glycosylases | 3 | 2017 | 125 | 0.800 |
Why?
|
| Animals | 120 | 2024 | 168800 | 0.790 |
Why?
|
| src Homology Domains | 10 | 2014 | 361 | 0.790 |
Why?
|
| Phosphoproteins | 4 | 2015 | 2445 | 0.780 |
Why?
|
| Protein Array Analysis | 3 | 2022 | 398 | 0.770 |
Why?
|
| Recombinant Fusion Proteins | 12 | 2018 | 3733 | 0.770 |
Why?
|
| Nuclear Proteins | 24 | 2022 | 5791 | 0.770 |
Why?
|
| Proto-Oncogene Proteins c-abl | 4 | 2018 | 145 | 0.760 |
Why?
|
| Oxidoreductases, N-Demethylating | 5 | 2007 | 110 | 0.740 |
Why?
|
| Phosphotyrosine | 5 | 2009 | 459 | 0.720 |
Why?
|
| Threonine | 2 | 2018 | 272 | 0.720 |
Why?
|
| Signal Transduction | 25 | 2024 | 23605 | 0.710 |
Why?
|
| Protein Structure, Tertiary | 25 | 2019 | 3751 | 0.700 |
Why?
|
| Enzyme Activation | 17 | 2020 | 3584 | 0.670 |
Why?
|
| Tranylcypromine | 2 | 2018 | 30 | 0.670 |
Why?
|
| Epigenesis, Genetic | 12 | 2024 | 3818 | 0.650 |
Why?
|
| Saccharomyces cerevisiae Proteins | 10 | 2024 | 1836 | 0.650 |
Why?
|
| Oxazepines | 1 | 2019 | 22 | 0.640 |
Why?
|
| Hydrazines | 2 | 2018 | 223 | 0.610 |
Why?
|
| Benzamides | 5 | 2019 | 1376 | 0.610 |
Why?
|
| Prodrugs | 3 | 2006 | 274 | 0.610 |
Why?
|
| Biotin | 3 | 2018 | 255 | 0.610 |
Why?
|
| Adenosine Triphosphate | 9 | 2014 | 2003 | 0.600 |
Why?
|
| Replication Protein A | 2 | 2018 | 54 | 0.600 |
Why?
|
| Receptor, Adenosine A2A | 2 | 2016 | 128 | 0.600 |
Why?
|
| Peptide Fragments | 11 | 2016 | 5126 | 0.590 |
Why?
|
| Drug Design | 8 | 2018 | 1040 | 0.580 |
Why?
|
| Acetyl Coenzyme A | 11 | 2017 | 74 | 0.580 |
Why?
|
| Transcription Factors | 24 | 2024 | 12130 | 0.570 |
Why?
|
| Binding Sites | 27 | 2024 | 6001 | 0.570 |
Why?
|
| Benzoates | 4 | 2016 | 213 | 0.540 |
Why?
|
| Bromine Compounds | 1 | 2016 | 2 | 0.540 |
Why?
|
| Tryptamines | 8 | 2024 | 93 | 0.530 |
Why?
|
| Adenosine A2 Receptor Antagonists | 1 | 2016 | 50 | 0.530 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2017 | 284 | 0.530 |
Why?
|
| CREB-Binding Protein | 9 | 2021 | 146 | 0.530 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2016 | 62 | 0.520 |
Why?
|
| Melatonin | 8 | 2023 | 670 | 0.520 |
Why?
|
| Nerve Tissue Proteins | 5 | 2020 | 4399 | 0.520 |
Why?
|
| Chromatin Assembly and Disassembly | 5 | 2017 | 632 | 0.510 |
Why?
|
| Trans-Activators | 17 | 2012 | 2849 | 0.510 |
Why?
|
| Methylation | 7 | 2020 | 1074 | 0.500 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 5 | 2017 | 484 | 0.500 |
Why?
|
| Phytic Acid | 1 | 2015 | 22 | 0.490 |
Why?
|
| Receptor, Insulin | 7 | 2017 | 838 | 0.490 |
Why?
|
| Adenosylhomocysteinase | 1 | 2014 | 3 | 0.480 |
Why?
|
| Humans | 162 | 2024 | 766117 | 0.470 |
Why?
|
| Gene Silencing | 4 | 2024 | 1504 | 0.470 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2016 | 443 | 0.470 |
Why?
|
| Point Mutation | 8 | 2018 | 1591 | 0.470 |
Why?
|
| Phosphopeptides | 4 | 2018 | 240 | 0.470 |
Why?
|
| Phenelzine | 1 | 2014 | 28 | 0.460 |
Why?
|
| Triazines | 1 | 2016 | 311 | 0.460 |
Why?
|
| Repressor Proteins | 7 | 2021 | 2974 | 0.450 |
Why?
|
| Autophagy | 1 | 2022 | 1349 | 0.450 |
Why?
|
| Phenethylamines | 1 | 2014 | 95 | 0.440 |
Why?
|
| Imidazoles | 3 | 2012 | 1169 | 0.440 |
Why?
|
| Chemical Engineering | 1 | 2013 | 15 | 0.440 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2013 | 2898 | 0.440 |
Why?
|
| Escherichia coli | 13 | 2018 | 4210 | 0.440 |
Why?
|
| Allosteric Regulation | 5 | 2018 | 425 | 0.410 |
Why?
|
| HeLa Cells | 15 | 2020 | 3073 | 0.410 |
Why?
|
| Aza Compounds | 1 | 2012 | 34 | 0.390 |
Why?
|
| Cell Line, Tumor | 24 | 2024 | 17071 | 0.390 |
Why?
|
| Protein Stability | 5 | 2024 | 576 | 0.390 |
Why?
|
| Mice | 48 | 2024 | 81839 | 0.390 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2014 | 287 | 0.380 |
Why?
|
| Chemistry, Pharmaceutical | 2 | 2005 | 273 | 0.380 |
Why?
|
| Casein Kinase II | 1 | 2012 | 120 | 0.370 |
Why?
|
| Cell Line | 23 | 2020 | 15546 | 0.370 |
Why?
|
| Histone Deacetylase 2 | 2 | 2021 | 71 | 0.370 |
Why?
|
| Melanoma | 7 | 2024 | 5695 | 0.370 |
Why?
|
| Membrane Proteins | 7 | 2019 | 7850 | 0.370 |
Why?
|
| Biology | 1 | 2013 | 293 | 0.370 |
Why?
|
| Protein Biosynthesis | 1 | 2018 | 2091 | 0.370 |
Why?
|
| Sulfhydryl Compounds | 5 | 2020 | 296 | 0.360 |
Why?
|
| Triazoles | 1 | 2016 | 902 | 0.360 |
Why?
|
| Drug Discovery | 3 | 2021 | 1065 | 0.360 |
Why?
|
| HCT116 Cells | 3 | 2021 | 399 | 0.360 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2016 | 1331 | 0.360 |
Why?
|
| Science | 1 | 2013 | 234 | 0.350 |
Why?
|
| Cell Proliferation | 11 | 2024 | 10433 | 0.350 |
Why?
|
| Spodoptera | 4 | 2018 | 140 | 0.350 |
Why?
|
| Acetylglucosamine | 1 | 2012 | 189 | 0.350 |
Why?
|
| Piperidines | 1 | 2019 | 1664 | 0.350 |
Why?
|
| Thiocyanates | 1 | 2010 | 70 | 0.350 |
Why?
|
| Fluorescence Resonance Energy Transfer | 4 | 2017 | 415 | 0.350 |
Why?
|
| Carrier Proteins | 2 | 2019 | 4910 | 0.340 |
Why?
|
| Pyridines | 3 | 2019 | 2889 | 0.340 |
Why?
|
| Fluorescent Dyes | 4 | 2018 | 1928 | 0.340 |
Why?
|
| Protein Kinase Inhibitors | 9 | 2024 | 5695 | 0.330 |
Why?
|
| Sequence Homology, Amino Acid | 7 | 2014 | 2743 | 0.330 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 8 | 2010 | 505 | 0.330 |
Why?
|
| Phosphoamino Acids | 1 | 2009 | 6 | 0.320 |
Why?
|
| Epigenomics | 1 | 2015 | 959 | 0.320 |
Why?
|
| Adenosine | 1 | 2014 | 813 | 0.320 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 2 | 2023 | 257 | 0.310 |
Why?
|
| Proteomics | 4 | 2018 | 3907 | 0.310 |
Why?
|
| Biomimetic Materials | 1 | 2010 | 170 | 0.310 |
Why?
|
| Amino Acid Substitution | 4 | 2009 | 1742 | 0.310 |
Why?
|
| Uracil-DNA Glycosidase | 2 | 2018 | 35 | 0.310 |
Why?
|
| Energy Metabolism | 1 | 2019 | 2894 | 0.300 |
Why?
|
| Oligopeptides | 3 | 2004 | 1195 | 0.300 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 5 | 2019 | 501 | 0.300 |
Why?
|
| Magnetic Resonance Spectroscopy | 8 | 2021 | 3678 | 0.300 |
Why?
|
| Rhodanine | 2 | 2023 | 6 | 0.300 |
Why?
|
| Fluorescence Polarization | 2 | 2021 | 140 | 0.300 |
Why?
|
| Saccharomyces cerevisiae | 5 | 2024 | 2677 | 0.300 |
Why?
|
| Chickens | 6 | 2013 | 842 | 0.290 |
Why?
|
| Leukemia | 1 | 2016 | 1522 | 0.290 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2007 | 28 | 0.290 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2007 | 44 | 0.290 |
Why?
|
| Transcription, Genetic | 15 | 2017 | 7600 | 0.290 |
Why?
|
| Mass Spectrometry | 8 | 2018 | 2195 | 0.290 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 3 | 2014 | 169 | 0.280 |
Why?
|
| Pantetheine | 1 | 2006 | 3 | 0.280 |
Why?
|
| DNA Methylation | 3 | 2019 | 4425 | 0.280 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2013 | 2795 | 0.270 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2020 | 2476 | 0.270 |
Why?
|
| Protein Multimerization | 3 | 2024 | 959 | 0.270 |
Why?
|
| Pineal Gland | 5 | 2007 | 154 | 0.270 |
Why?
|
| Organophosphorus Compounds | 2 | 2006 | 209 | 0.270 |
Why?
|
| Binding, Competitive | 7 | 2017 | 1140 | 0.270 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2018 | 327 | 0.270 |
Why?
|
| Hydrogen Bonding | 5 | 2014 | 290 | 0.260 |
Why?
|
| Amino Acids | 4 | 2023 | 1710 | 0.260 |
Why?
|
| Alanine | 2 | 2009 | 613 | 0.260 |
Why?
|
| Cloning, Molecular | 5 | 2020 | 4163 | 0.260 |
Why?
|
| Immunoconjugates | 1 | 2014 | 976 | 0.260 |
Why?
|
| Mitochondrial Proteins | 2 | 2018 | 975 | 0.260 |
Why?
|
| DNA | 7 | 2021 | 7193 | 0.260 |
Why?
|
| HEK293 Cells | 9 | 2024 | 4263 | 0.250 |
Why?
|
| Inteins | 2 | 2020 | 10 | 0.250 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 3 | 2017 | 267 | 0.250 |
Why?
|
| Cell Survival | 8 | 2019 | 5747 | 0.250 |
Why?
|
| Mutation | 20 | 2021 | 30209 | 0.250 |
Why?
|
| Alkylation | 2 | 2018 | 84 | 0.240 |
Why?
|
| Transfection | 8 | 2019 | 5739 | 0.240 |
Why?
|
| Methane | 1 | 2005 | 44 | 0.240 |
Why?
|
| Multiprotein Complexes | 2 | 2022 | 1107 | 0.240 |
Why?
|
| RNA Polymerase II | 5 | 2019 | 549 | 0.230 |
Why?
|
| Immunologic Factors | 1 | 2014 | 1592 | 0.230 |
Why?
|
| Glutathione Transferase | 5 | 2018 | 563 | 0.230 |
Why?
|
| Pentanoic Acids | 1 | 2004 | 19 | 0.230 |
Why?
|
| Pyrazoles | 3 | 2015 | 2031 | 0.230 |
Why?
|
| SOXE Transcription Factors | 1 | 2024 | 74 | 0.230 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2018 | 3796 | 0.230 |
Why?
|
| Alkyl and Aryl Transferases | 2 | 2002 | 89 | 0.230 |
Why?
|
| Protein Interaction Domains and Motifs | 3 | 2019 | 447 | 0.230 |
Why?
|
| Transcriptional Activation | 9 | 2011 | 1743 | 0.230 |
Why?
|
| Blotting, Western | 5 | 2016 | 5020 | 0.220 |
Why?
|
| Cells, Cultured | 12 | 2016 | 18967 | 0.220 |
Why?
|
| High-Throughput Screening Assays | 3 | 2023 | 938 | 0.220 |
Why?
|
| 14-3-3 Proteins | 1 | 2005 | 221 | 0.220 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 7 | 2011 | 2879 | 0.220 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2024 | 170 | 0.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 9 | 2024 | 8612 | 0.210 |
Why?
|
| Cross-Linking Reagents | 2 | 2005 | 687 | 0.210 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2019 | 2877 | 0.200 |
Why?
|
| K562 Cells | 1 | 2024 | 644 | 0.200 |
Why?
|
| Small Molecule Libraries | 3 | 2020 | 740 | 0.200 |
Why?
|
| Glycosyltransferases | 1 | 2023 | 114 | 0.200 |
Why?
|
| Rhodamines | 2 | 2018 | 178 | 0.200 |
Why?
|
| Ciona intestinalis | 1 | 2021 | 10 | 0.190 |
Why?
|
| Bacterial Proteins | 3 | 2024 | 3830 | 0.190 |
Why?
|
| Cell Cycle | 4 | 2024 | 2920 | 0.190 |
Why?
|
| Aromatase | 3 | 1990 | 147 | 0.190 |
Why?
|
| Hydantoins | 1 | 2021 | 12 | 0.190 |
Why?
|
| Acylation | 2 | 2012 | 98 | 0.190 |
Why?
|
| Sulfoxides | 3 | 2013 | 47 | 0.190 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2021 | 58 | 0.180 |
Why?
|
| COS Cells | 4 | 2012 | 1135 | 0.180 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2020 | 3604 | 0.180 |
Why?
|
| Mice, Knockout | 10 | 2021 | 14456 | 0.180 |
Why?
|
| Models, Chemical | 5 | 2006 | 607 | 0.180 |
Why?
|
| Spiro Compounds | 1 | 2021 | 69 | 0.180 |
Why?
|
| Neoplasms | 5 | 2022 | 22344 | 0.180 |
Why?
|
| Biological Products | 1 | 2010 | 947 | 0.180 |
Why?
|
| Protein Methyltransferases | 1 | 2020 | 53 | 0.180 |
Why?
|
| Rats | 10 | 2019 | 23717 | 0.180 |
Why?
|
| Cytosine | 1 | 2021 | 212 | 0.180 |
Why?
|
| Weight Gain | 1 | 2010 | 2356 | 0.170 |
Why?
|
| Molecular Chaperones | 3 | 2011 | 760 | 0.170 |
Why?
|
| Ketones | 1 | 2001 | 183 | 0.170 |
Why?
|
| Protein Splicing | 1 | 2020 | 16 | 0.170 |
Why?
|
| Acyl Coenzyme A | 1 | 2000 | 56 | 0.170 |
Why?
|
| DNA-Binding Proteins | 10 | 2021 | 9601 | 0.170 |
Why?
|
| Uracil | 2 | 2018 | 210 | 0.170 |
Why?
|
| Phosphorus | 1 | 2001 | 336 | 0.170 |
Why?
|
| Gene Expression Regulation | 10 | 2019 | 11906 | 0.170 |
Why?
|
| Xenopus laevis | 4 | 2018 | 965 | 0.170 |
Why?
|
| Tyrosine Phenol-Lyase | 1 | 1999 | 1 | 0.170 |
Why?
|
| Methyltyrosines | 1 | 1999 | 7 | 0.170 |
Why?
|
| Quinazolines | 4 | 2011 | 1366 | 0.170 |
Why?
|
| Arginine | 2 | 2000 | 931 | 0.160 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2020 | 116 | 0.160 |
Why?
|
| Receptors, Notch | 1 | 2024 | 751 | 0.160 |
Why?
|
| Leukemia, Myeloid, Acute | 5 | 2024 | 3637 | 0.160 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2001 | 415 | 0.160 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 1999 | 93 | 0.160 |
Why?
|
| Ubiquitins | 1 | 2021 | 365 | 0.160 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2004 | 1167 | 0.160 |
Why?
|
| Prostatic Neoplasms | 3 | 2019 | 11094 | 0.160 |
Why?
|
| Biotechnology | 1 | 2001 | 284 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 11 | 2019 | 5784 | 0.160 |
Why?
|
| SH2 Domain-Containing Protein Tyrosine Phosphatases | 3 | 2003 | 43 | 0.160 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2021 | 386 | 0.160 |
Why?
|
| 3T3 Cells | 3 | 2018 | 1079 | 0.160 |
Why?
|
| Computer Simulation | 3 | 2011 | 6254 | 0.160 |
Why?
|
| Clathrin | 1 | 2020 | 259 | 0.160 |
Why?
|
| Glucose | 1 | 2010 | 4335 | 0.160 |
Why?
|
| Extinction, Psychological | 2 | 2012 | 367 | 0.150 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2020 | 299 | 0.150 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2021 | 481 | 0.150 |
Why?
|
| Antineoplastic Agents | 8 | 2020 | 13635 | 0.150 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2024 | 1363 | 0.150 |
Why?
|
| Forkhead Transcription Factors | 3 | 2014 | 1623 | 0.150 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2020 | 3112 | 0.150 |
Why?
|
| Deuterium Exchange Measurement | 2 | 2014 | 31 | 0.150 |
Why?
|
| Mutant Proteins | 5 | 2011 | 487 | 0.150 |
Why?
|
| Fluoresceins | 1 | 2018 | 235 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 6 | 2020 | 6102 | 0.150 |
Why?
|
| Pyrazolones | 3 | 2015 | 8 | 0.150 |
Why?
|
| Muscle Proteins | 1 | 2023 | 1160 | 0.150 |
Why?
|
| Plasmids | 4 | 2014 | 2267 | 0.150 |
Why?
|
| Sequence Deletion | 5 | 2014 | 1494 | 0.150 |
Why?
|
| Sheep | 4 | 2005 | 1445 | 0.140 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 3 | 2003 | 225 | 0.140 |
Why?
|
| Brain Stem Neoplasms | 1 | 2019 | 192 | 0.140 |
Why?
|
| Immunoprecipitation | 3 | 2016 | 874 | 0.140 |
Why?
|
| Thymine DNA Glycosylase | 1 | 2016 | 7 | 0.140 |
Why?
|
| GTPase-Activating Proteins | 1 | 2020 | 465 | 0.140 |
Why?
|
| Embryo, Mammalian | 2 | 2014 | 1674 | 0.140 |
Why?
|
| Biomimetics | 1 | 2018 | 168 | 0.140 |
Why?
|
| Adenosine Triphosphatases | 1 | 2001 | 839 | 0.140 |
Why?
|
| Peptide Library | 2 | 2014 | 351 | 0.140 |
Why?
|
| Enzyme Stability | 1 | 2017 | 218 | 0.140 |
Why?
|
| Cations, Divalent | 1 | 1997 | 167 | 0.140 |
Why?
|
| Germ Cells | 1 | 2021 | 646 | 0.140 |
Why?
|
| Biotinylation | 2 | 2007 | 184 | 0.130 |
Why?
|
| Oncogenes | 1 | 2022 | 1232 | 0.130 |
Why?
|
| Chaperonin 10 | 1 | 1996 | 14 | 0.130 |
Why?
|
| DNA, Single-Stranded | 1 | 2018 | 351 | 0.130 |
Why?
|
| Receptor, erbB-2 | 2 | 2008 | 2593 | 0.130 |
Why?
|
| Membrane Transport Proteins | 1 | 2022 | 1029 | 0.130 |
Why?
|
| Neoplasm Proteins | 3 | 2020 | 3594 | 0.130 |
Why?
|
| Conserved Sequence | 5 | 2014 | 1159 | 0.130 |
Why?
|
| Reminder Systems | 1 | 2019 | 388 | 0.130 |
Why?
|
| Models, Theoretical | 1 | 2008 | 3561 | 0.130 |
Why?
|
| Gene Expression | 5 | 2020 | 7582 | 0.130 |
Why?
|
| Diet | 2 | 2013 | 8087 | 0.130 |
Why?
|
| Endotoxemia | 1 | 2017 | 198 | 0.130 |
Why?
|
| Chaperonin 60 | 1 | 1996 | 97 | 0.130 |
Why?
|
| Indoles | 2 | 2001 | 1833 | 0.130 |
Why?
|
| Early Detection of Cancer | 2 | 2021 | 3238 | 0.130 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2018 | 429 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 4 | 2020 | 6215 | 0.120 |
Why?
|
| NIH 3T3 Cells | 3 | 2006 | 651 | 0.120 |
Why?
|
| Drosophila Proteins | 4 | 2024 | 1704 | 0.120 |
Why?
|
| Baculoviridae | 1 | 2015 | 115 | 0.120 |
Why?
|
| Neurons | 2 | 2014 | 9521 | 0.120 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2018 | 715 | 0.120 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 904 | 0.120 |
Why?
|
| Ligands | 7 | 2014 | 3274 | 0.120 |
Why?
|
| Oncogene Proteins | 3 | 2010 | 711 | 0.120 |
Why?
|
| Dimerization | 5 | 2008 | 881 | 0.120 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2018 | 455 | 0.120 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2019 | 540 | 0.120 |
Why?
|
| Zebrafish | 2 | 2023 | 3035 | 0.120 |
Why?
|
| Amidohydrolases | 1 | 2015 | 160 | 0.120 |
Why?
|
| Drug Synergism | 1 | 2019 | 1754 | 0.120 |
Why?
|
| Benzimidazoles | 1 | 2020 | 862 | 0.120 |
Why?
|
| Neoplasms, Experimental | 1 | 2020 | 1227 | 0.120 |
Why?
|
| Vaccinia virus | 1 | 2016 | 328 | 0.120 |
Why?
|
| Protein Structure, Secondary | 3 | 2013 | 1211 | 0.120 |
Why?
|
| Pyridones | 1 | 2020 | 817 | 0.120 |
Why?
|
| Fibroblasts | 3 | 2016 | 4162 | 0.120 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2014 | 39 | 0.120 |
Why?
|
| Endopeptidases | 1 | 2018 | 760 | 0.120 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2021 | 4049 | 0.120 |
Why?
|
| Skin | 2 | 2023 | 4482 | 0.120 |
Why?
|
| Cyclopropanes | 1 | 2016 | 436 | 0.120 |
Why?
|
| Reperfusion Injury | 1 | 2021 | 1043 | 0.110 |
Why?
|
| Escherichia coli Proteins | 2 | 2015 | 1056 | 0.110 |
Why?
|
| Sialoglycoproteins | 1 | 2015 | 313 | 0.110 |
Why?
|
| Immunity, Cellular | 1 | 2020 | 1557 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 9 | 2017 | 22341 | 0.110 |
Why?
|
| Drosophila melanogaster | 3 | 2024 | 1725 | 0.110 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2018 | 1527 | 0.110 |
Why?
|
| Phenylalanine | 2 | 2009 | 367 | 0.110 |
Why?
|
| Hydrolases | 1 | 2014 | 146 | 0.110 |
Why?
|
| Monoamine Oxidase | 1 | 2014 | 179 | 0.110 |
Why?
|
| Models, Biological | 8 | 2013 | 9445 | 0.110 |
Why?
|
| Gene Products, tat | 2 | 2004 | 111 | 0.110 |
Why?
|
| Aspartic Acid | 3 | 2002 | 575 | 0.110 |
Why?
|
| Cricetinae | 3 | 2013 | 2413 | 0.110 |
Why?
|
| Scattering, Small Angle | 1 | 2013 | 61 | 0.110 |
Why?
|
| Bacillus subtilis | 1 | 2016 | 356 | 0.110 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2013 | 289 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 1138 | 0.110 |
Why?
|
| RNA, Small Interfering | 6 | 2012 | 3424 | 0.110 |
Why?
|
| Skin Neoplasms | 3 | 2019 | 5836 | 0.110 |
Why?
|
| S-Adenosylmethionine | 1 | 2014 | 219 | 0.100 |
Why?
|
| Gene Products, tax | 2 | 2003 | 51 | 0.100 |
Why?
|
| Fear | 2 | 2012 | 1496 | 0.100 |
Why?
|
| Mice, SCID | 4 | 2021 | 2626 | 0.100 |
Why?
|
| Food Deprivation | 1 | 2013 | 115 | 0.100 |
Why?
|
| Cell Membrane | 3 | 2018 | 3635 | 0.100 |
Why?
|
| Guanine Nucleotide-Releasing Factor 2 | 1 | 2012 | 5 | 0.100 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2014 | 250 | 0.100 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2014 | 698 | 0.100 |
Why?
|
| Chromatography, Liquid | 1 | 2016 | 992 | 0.100 |
Why?
|
| After-Hours Care | 1 | 2013 | 102 | 0.100 |
Why?
|
| Immunoassay | 1 | 2016 | 742 | 0.100 |
Why?
|
| rap1 GTP-Binding Proteins | 1 | 2012 | 51 | 0.100 |
Why?
|
| Receptors, Ghrelin | 1 | 2012 | 20 | 0.100 |
Why?
|
| Sequence Alignment | 4 | 2010 | 2174 | 0.100 |
Why?
|
| Carbamates | 1 | 2013 | 191 | 0.100 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 2 | 2002 | 121 | 0.100 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2014 | 385 | 0.100 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2005 | 694 | 0.100 |
Why?
|
| Insulin-Secreting Cells | 1 | 2019 | 899 | 0.100 |
Why?
|
| Protein Folding | 1 | 1996 | 868 | 0.100 |
Why?
|
| Lipids | 1 | 2023 | 3316 | 0.100 |
Why?
|
| Focal Adhesions | 1 | 2012 | 113 | 0.100 |
Why?
|
| Serotonin | 3 | 2002 | 1045 | 0.100 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2012 | 98 | 0.100 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2011 | 385 | 0.100 |
Why?
|
| Leisure Activities | 1 | 2013 | 310 | 0.090 |
Why?
|
| CHO Cells | 2 | 2005 | 1373 | 0.090 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2021 | 1404 | 0.090 |
Why?
|
| Antibodies | 2 | 2018 | 2415 | 0.090 |
Why?
|
| Mice, Nude | 1 | 2018 | 3610 | 0.090 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2016 | 605 | 0.090 |
Why?
|
| Herpesvirus 4, Human | 2 | 2009 | 1077 | 0.090 |
Why?
|
| Colonoscopy | 1 | 2019 | 1408 | 0.090 |
Why?
|
| Cell Differentiation | 4 | 2024 | 11642 | 0.090 |
Why?
|
| Chemoprevention | 1 | 2013 | 327 | 0.090 |
Why?
|
| Inhibitory Concentration 50 | 3 | 2014 | 463 | 0.090 |
Why?
|
| Genes, Reporter | 3 | 2011 | 1524 | 0.090 |
Why?
|
| Biosensing Techniques | 1 | 2017 | 640 | 0.090 |
Why?
|
| Aziridines | 1 | 2010 | 23 | 0.090 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2013 | 422 | 0.090 |
Why?
|
| Magnesium | 3 | 2001 | 815 | 0.090 |
Why?
|
| Hydroxytestosterones | 1 | 1990 | 4 | 0.090 |
Why?
|
| Placenta | 2 | 1990 | 1726 | 0.090 |
Why?
|
| Protons | 2 | 2009 | 1073 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 1883 | 0.090 |
Why?
|
| Pargyline | 1 | 2010 | 19 | 0.090 |
Why?
|
| Electrons | 2 | 2010 | 264 | 0.090 |
Why?
|
| Mortality | 1 | 2002 | 2911 | 0.090 |
Why?
|
| Biological Assay | 1 | 2013 | 626 | 0.090 |
Why?
|
| HIV Fusion Inhibitors | 1 | 2010 | 82 | 0.090 |
Why?
|
| NAD | 1 | 2014 | 618 | 0.090 |
Why?
|
| Endoderm | 1 | 2011 | 165 | 0.090 |
Why?
|
| Isothiocyanates | 1 | 2010 | 48 | 0.090 |
Why?
|
| Androstenedione | 1 | 1990 | 138 | 0.090 |
Why?
|
| Chromatography, Gel | 2 | 2018 | 631 | 0.090 |
Why?
|
| Potassium Channels | 2 | 2005 | 534 | 0.090 |
Why?
|
| Alkaline Phosphatase | 1 | 2013 | 855 | 0.090 |
Why?
|
| Male | 23 | 2021 | 363935 | 0.080 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2024 | 1609 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2024 | 3606 | 0.080 |
Why?
|
| Accreditation | 1 | 2013 | 476 | 0.080 |
Why?
|
| Microscopy, Confocal | 3 | 2012 | 1967 | 0.080 |
Why?
|
| Macrophages, Peritoneal | 1 | 2011 | 243 | 0.080 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 1194 | 0.080 |
Why?
|
| Insulin | 2 | 2017 | 6604 | 0.080 |
Why?
|
| Multipotent Stem Cells | 1 | 2011 | 200 | 0.080 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2013 | 545 | 0.080 |
Why?
|
| Colorectal Neoplasms | 2 | 2019 | 6961 | 0.080 |
Why?
|
| Protein Transport | 1 | 2015 | 1939 | 0.080 |
Why?
|
| Protein Sorting Signals | 1 | 2010 | 273 | 0.080 |
Why?
|
| Guanidine | 1 | 2009 | 35 | 0.080 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2011 | 393 | 0.080 |
Why?
|
| Triiodothyronine | 2 | 2009 | 493 | 0.080 |
Why?
|
| Propylamines | 1 | 2010 | 161 | 0.080 |
Why?
|
| Computational Biology | 2 | 2013 | 3565 | 0.080 |
Why?
|
| RNA, Neoplasm | 1 | 2012 | 745 | 0.080 |
Why?
|
| Receptors, Thyroid Hormone | 3 | 2009 | 202 | 0.080 |
Why?
|
| Butyrates | 1 | 2010 | 164 | 0.080 |
Why?
|
| Transducin | 2 | 2009 | 42 | 0.080 |
Why?
|
| Glycoprotein Hormones, alpha Subunit | 1 | 2009 | 95 | 0.080 |
Why?
|
| Genetic Vectors | 3 | 2015 | 3400 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2011 | 2838 | 0.080 |
Why?
|
| Liver | 3 | 2017 | 7559 | 0.080 |
Why?
|
| Oxidation-Reduction | 2 | 2023 | 2221 | 0.080 |
Why?
|
| Phosphothreonine | 1 | 2009 | 62 | 0.080 |
Why?
|
| Smad3 Protein | 1 | 2009 | 165 | 0.080 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2011 | 352 | 0.080 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2005 | 723 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2019 | 2694 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3665 | 0.080 |
Why?
|
| Up-Regulation | 3 | 2013 | 4133 | 0.080 |
Why?
|
| Epidermal Growth Factor | 1 | 2011 | 697 | 0.080 |
Why?
|
| Carcinoma | 1 | 2020 | 2313 | 0.080 |
Why?
|
| Respiratory Tract Infections | 1 | 2016 | 1008 | 0.080 |
Why?
|
| Phosphoserine | 1 | 2009 | 203 | 0.080 |
Why?
|
| DNA Damage | 2 | 2013 | 2463 | 0.080 |
Why?
|
| Dogs | 1 | 2013 | 3824 | 0.080 |
Why?
|
| RNA Interference | 3 | 2012 | 2828 | 0.080 |
Why?
|
| Structural Homology, Protein | 1 | 2008 | 86 | 0.080 |
Why?
|
| Cell Lineage | 1 | 2017 | 2573 | 0.080 |
Why?
|
| Homeostasis | 2 | 2010 | 3338 | 0.080 |
Why?
|
| Circadian Rhythm | 3 | 2008 | 2594 | 0.080 |
Why?
|
| Macrophages, Alveolar | 1 | 2011 | 413 | 0.080 |
Why?
|
| Allosteric Site | 1 | 2018 | 106 | 0.070 |
Why?
|
| Flavins | 1 | 2007 | 17 | 0.070 |
Why?
|
| Glucose Tolerance Test | 1 | 2010 | 1180 | 0.070 |
Why?
|
| Leucine Zippers | 1 | 2007 | 116 | 0.070 |
Why?
|
| DNA Repair | 1 | 2016 | 2048 | 0.070 |
Why?
|
| RNA Polymerase III | 1 | 2007 | 59 | 0.070 |
Why?
|
| Hyaluronic Acid | 1 | 2011 | 483 | 0.070 |
Why?
|
| Virus Activation | 1 | 2009 | 322 | 0.070 |
Why?
|
| Photochemistry | 2 | 2002 | 238 | 0.070 |
Why?
|
| Health Promotion | 1 | 2019 | 2209 | 0.070 |
Why?
|
| DNA Primers | 3 | 2012 | 2824 | 0.070 |
Why?
|
| Spectrophotometry | 1 | 2007 | 291 | 0.070 |
Why?
|
| Isoenzymes | 2 | 2021 | 1688 | 0.070 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2024 | 657 | 0.070 |
Why?
|
| Virus Internalization | 1 | 2010 | 503 | 0.070 |
Why?
|
| Aminopeptidases | 1 | 2007 | 113 | 0.070 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2014 | 1935 | 0.070 |
Why?
|
| Tauopathies | 1 | 2010 | 325 | 0.070 |
Why?
|
| Aromatase Inhibitors | 1 | 1990 | 518 | 0.070 |
Why?
|
| Estrogens | 2 | 1990 | 1528 | 0.070 |
Why?
|
| Fetus | 1 | 2014 | 1878 | 0.070 |
Why?
|
| Database Management Systems | 1 | 2008 | 263 | 0.070 |
Why?
|
| Flavin-Adenine Dinucleotide | 1 | 2006 | 30 | 0.070 |
Why?
|
| Zinc Fingers | 2 | 2005 | 575 | 0.070 |
Why?
|
| Mice, Inbred NOD | 2 | 2021 | 1837 | 0.070 |
Why?
|
| Cyclin A | 1 | 2006 | 59 | 0.070 |
Why?
|
| Circular Dichroism | 1 | 2006 | 333 | 0.070 |
Why?
|
| Mammals | 2 | 2023 | 1126 | 0.070 |
Why?
|
| Educational Measurement | 1 | 2013 | 1260 | 0.060 |
Why?
|
| Eating | 1 | 2013 | 1538 | 0.060 |
Why?
|
| Cell Culture Techniques | 2 | 2011 | 1651 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2024 | 10737 | 0.060 |
Why?
|
| Formaldehyde | 2 | 2004 | 360 | 0.060 |
Why?
|
| Gene Expression Profiling | 4 | 2017 | 9527 | 0.060 |
Why?
|
| Transcription Factor AP-1 | 2 | 2005 | 322 | 0.060 |
Why?
|
| Tetrahymena | 1 | 2005 | 10 | 0.060 |
Why?
|
| Molecular Weight | 2 | 2006 | 2161 | 0.060 |
Why?
|
| Stereoisomerism | 2 | 2001 | 612 | 0.060 |
Why?
|
| Gene Knockout Techniques | 2 | 2019 | 800 | 0.060 |
Why?
|
| F-Box Proteins | 1 | 2007 | 199 | 0.060 |
Why?
|
| Colitis | 1 | 2014 | 1240 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2006 | 185 | 0.060 |
Why?
|
| Ion Channels | 1 | 2010 | 1044 | 0.060 |
Why?
|
| Protein Prenylation | 1 | 2005 | 69 | 0.060 |
Why?
|
| Mutagenesis, Insertional | 1 | 2008 | 663 | 0.060 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2006 | 178 | 0.060 |
Why?
|
| Databases, Protein | 1 | 2008 | 391 | 0.060 |
Why?
|
| Intranuclear Space | 1 | 2005 | 15 | 0.060 |
Why?
|
| Fourier Analysis | 1 | 2006 | 434 | 0.060 |
Why?
|
| Nitrophenols | 1 | 2006 | 169 | 0.060 |
Why?
|
| Proteome | 2 | 2023 | 1896 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2014 | 8113 | 0.060 |
Why?
|
| Bacteriocins | 1 | 2005 | 85 | 0.060 |
Why?
|
| Ribonucleotide Reductases | 1 | 2005 | 75 | 0.060 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2009 | 637 | 0.060 |
Why?
|
| Azepines | 1 | 2007 | 328 | 0.060 |
Why?
|
| Human T-lymphotropic virus 1 | 2 | 2003 | 143 | 0.060 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2005 | 112 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2011 | 856 | 0.060 |
Why?
|
| Steroids | 1 | 1990 | 934 | 0.060 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2021 | 3405 | 0.060 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2024 | 40 | 0.060 |
Why?
|
| Glutathione | 1 | 2007 | 589 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 1 | 2010 | 1322 | 0.060 |
Why?
|
| Nitrobenzenes | 2 | 2015 | 64 | 0.060 |
Why?
|
| Glioma | 1 | 2019 | 3491 | 0.060 |
Why?
|
| Viscosity | 2 | 1995 | 334 | 0.060 |
Why?
|
| Body Weight | 2 | 2013 | 4626 | 0.060 |
Why?
|
| Islets of Langerhans | 1 | 2010 | 1349 | 0.060 |
Why?
|
| Hydrocarbons | 1 | 2005 | 105 | 0.060 |
Why?
|
| Pancreas | 1 | 2011 | 1699 | 0.060 |
Why?
|
| Chemical Industry | 1 | 2004 | 115 | 0.060 |
Why?
|
| Apoptosis | 5 | 2020 | 9508 | 0.060 |
Why?
|
| Cyclins | 2 | 2003 | 598 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2014 | 4408 | 0.060 |
Why?
|
| Growth Substances | 1 | 2006 | 758 | 0.050 |
Why?
|
| Protease Inhibitors | 1 | 2007 | 750 | 0.050 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2004 | 177 | 0.050 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2024 | 196 | 0.050 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2005 | 249 | 0.050 |
Why?
|
| Tryptophan | 1 | 2005 | 483 | 0.050 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2004 | 158 | 0.050 |
Why?
|
| Disease Models, Animal | 5 | 2024 | 18321 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 2011 | 13483 | 0.050 |
Why?
|
| Protein Phosphatase 1 | 1 | 2003 | 135 | 0.050 |
Why?
|
| Fluorescein | 1 | 2003 | 175 | 0.050 |
Why?
|
| SEER Program | 1 | 2008 | 1443 | 0.050 |
Why?
|
| Female | 18 | 2021 | 396233 | 0.050 |
Why?
|
| Nucleotides | 1 | 2005 | 453 | 0.050 |
Why?
|
| Neuronal Plasticity | 1 | 2011 | 1447 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 1724 | 0.050 |
Why?
|
| Genes, fos | 2 | 2013 | 176 | 0.050 |
Why?
|
| Information Storage and Retrieval | 1 | 2008 | 831 | 0.050 |
Why?
|
| Phenanthrenes | 1 | 2002 | 65 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2009 | 1801 | 0.050 |
Why?
|
| Carcinogens | 1 | 2004 | 451 | 0.050 |
Why?
|
| Inflammation Mediators | 1 | 2011 | 1890 | 0.050 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2002 | 94 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2007 | 998 | 0.050 |
Why?
|
| Subtilisin | 1 | 2001 | 12 | 0.050 |
Why?
|
| Xenopus | 2 | 2020 | 709 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2006 | 4521 | 0.050 |
Why?
|
| Breast Neoplasms | 2 | 2013 | 21074 | 0.050 |
Why?
|
| General Surgery | 1 | 2013 | 1722 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2019 | 373 | 0.050 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2001 | 101 | 0.050 |
Why?
|
| Culture Media, Serum-Free | 1 | 2001 | 147 | 0.050 |
Why?
|
| Synapses | 1 | 2011 | 1759 | 0.050 |
Why?
|
| Muscle Development | 1 | 2023 | 258 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2005 | 1984 | 0.050 |
Why?
|
| Memory | 1 | 2011 | 2192 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 1602 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2021 | 82 | 0.050 |
Why?
|
| Receptors, Androgen | 3 | 2017 | 1088 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2010 | 2142 | 0.050 |
Why?
|
| Endothelins | 1 | 2021 | 127 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2006 | 1241 | 0.050 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2021 | 72 | 0.050 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2001 | 103 | 0.050 |
Why?
|
| Base Sequence | 4 | 2018 | 12405 | 0.050 |
Why?
|
| Microinjections | 1 | 2001 | 319 | 0.040 |
Why?
|
| Estrogen Receptor alpha | 1 | 2005 | 580 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2024 | 694 | 0.040 |
Why?
|
| Sarcomeres | 1 | 2023 | 379 | 0.040 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2010 | 1433 | 0.040 |
Why?
|
| Anticarcinogenic Agents | 1 | 2002 | 250 | 0.040 |
Why?
|
| Cattle | 1 | 2006 | 3801 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2001 | 539 | 0.040 |
Why?
|
| Biological Availability | 1 | 2021 | 387 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2023 | 323 | 0.040 |
Why?
|
| tau Proteins | 1 | 2010 | 2110 | 0.040 |
Why?
|
| HIV-1 | 2 | 2010 | 6948 | 0.040 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2000 | 109 | 0.040 |
Why?
|
| Nanotechnology | 1 | 2005 | 702 | 0.040 |
Why?
|
| Maleimides | 1 | 2000 | 112 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 2 | 2010 | 2627 | 0.040 |
Why?
|
| Static Electricity | 1 | 2000 | 258 | 0.040 |
Why?
|
| Potassium Channel Blockers | 1 | 2000 | 162 | 0.040 |
Why?
|
| HT29 Cells | 1 | 2019 | 187 | 0.040 |
Why?
|
| Mice, Hairless | 1 | 2019 | 39 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2013 | 4782 | 0.040 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2000 | 204 | 0.040 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2012 | 2327 | 0.040 |
Why?
|
| Hematologic Neoplasms | 2 | 2017 | 1926 | 0.040 |
Why?
|
| Testosterone | 1 | 1990 | 2495 | 0.040 |
Why?
|
| Melanocytes | 1 | 2002 | 504 | 0.040 |
Why?
|
| Dioxygenases | 1 | 2021 | 354 | 0.040 |
Why?
|
| Pneumonia | 1 | 2011 | 2159 | 0.040 |
Why?
|
| Tretinoin | 1 | 2002 | 524 | 0.040 |
Why?
|
| Deoxyuracil Nucleotides | 1 | 2018 | 13 | 0.040 |
Why?
|
| Keratinocytes | 1 | 2023 | 861 | 0.040 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2001 | 501 | 0.040 |
Why?
|
| Occupational Exposure | 2 | 2011 | 1806 | 0.040 |
Why?
|
| Recombination, Genetic | 2 | 2010 | 1525 | 0.040 |
Why?
|
| Histone Code | 1 | 2019 | 160 | 0.040 |
Why?
|
| Receptors, Transferrin | 1 | 2020 | 300 | 0.040 |
Why?
|
| Pons | 1 | 2019 | 239 | 0.040 |
Why?
|
| Pyrophosphatases | 1 | 2019 | 143 | 0.040 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2010 | 1884 | 0.040 |
Why?
|
| Transcription Factor TFIIB | 1 | 2017 | 25 | 0.040 |
Why?
|
| Propionates | 1 | 1998 | 180 | 0.040 |
Why?
|
| Ion Channel Gating | 1 | 2000 | 428 | 0.040 |
Why?
|
| Alcoholic Intoxication | 1 | 1999 | 171 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2002 | 1716 | 0.040 |
Why?
|
| Nuclear Localization Signals | 1 | 2017 | 78 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 8038 | 0.040 |
Why?
|
| Down-Regulation | 3 | 2011 | 2927 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2023 | 1132 | 0.030 |
Why?
|
| Lysosomes | 1 | 2023 | 932 | 0.030 |
Why?
|
| Biological Transport | 2 | 2017 | 2080 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2012 | 6421 | 0.030 |
Why?
|
| Half-Life | 1 | 2018 | 645 | 0.030 |
Why?
|
| Mammography | 1 | 2008 | 2424 | 0.030 |
Why?
|
| Parkinson Disease | 1 | 2011 | 2885 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2004 | 2226 | 0.030 |
Why?
|
| Administration, Topical | 1 | 2019 | 702 | 0.030 |
Why?
|
| Phenotype | 2 | 2024 | 16716 | 0.030 |
Why?
|
| Cobalt | 1 | 1997 | 146 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 2018 | 390 | 0.030 |
Why?
|
| Lipopolysaccharides | 2 | 2017 | 2213 | 0.030 |
Why?
|
| Protozoan Proteins | 1 | 2002 | 843 | 0.030 |
Why?
|
| Hydroxamic Acids | 2 | 2011 | 483 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2017 | 417 | 0.030 |
Why?
|
| Nickel | 1 | 1997 | 126 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2012 | 4352 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 2011 | 4544 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2012 | 3787 | 0.030 |
Why?
|
| Occupational Diseases | 1 | 2004 | 1456 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 1997 | 655 | 0.030 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2018 | 222 | 0.030 |
Why?
|
| Cryoelectron Microscopy | 1 | 2020 | 645 | 0.030 |
Why?
|
| Integrins | 1 | 2020 | 838 | 0.030 |
Why?
|
| Stochastic Processes | 1 | 2017 | 358 | 0.030 |
Why?
|
| Internet | 1 | 2008 | 3107 | 0.030 |
Why?
|
| Disease Progression | 2 | 2023 | 13616 | 0.030 |
Why?
|
| Macrophages | 1 | 2010 | 5776 | 0.030 |
Why?
|
| Time Factors | 6 | 2011 | 40108 | 0.030 |
Why?
|
| Antidepressive Agents | 1 | 2007 | 2901 | 0.030 |
Why?
|
| Obesity | 1 | 2017 | 13085 | 0.030 |
Why?
|
| Isotopes | 1 | 1994 | 125 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2018 | 900 | 0.030 |
Why?
|
| Actins | 1 | 2002 | 2061 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 9237 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2019 | 752 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2019 | 1966 | 0.030 |
Why?
|
| Bucladesine | 1 | 2013 | 117 | 0.030 |
Why?
|
| Coenzymes | 1 | 2014 | 101 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2017 | 1644 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 2 | 2008 | 423 | 0.030 |
Why?
|
| Early Growth Response Protein 2 | 1 | 2013 | 25 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2024 | 2054 | 0.030 |
Why?
|
| HSP72 Heat-Shock Proteins | 1 | 2013 | 40 | 0.030 |
Why?
|
| Test Taking Skills | 1 | 2013 | 10 | 0.030 |
Why?
|
| GATA3 Transcription Factor | 1 | 2014 | 163 | 0.030 |
Why?
|
| Mutagenesis | 2 | 2008 | 1227 | 0.030 |
Why?
|
| Automobile Driving | 1 | 1999 | 441 | 0.030 |
Why?
|
| Amino Acid Motifs | 2 | 2006 | 924 | 0.030 |
Why?
|
| Louisiana | 1 | 2013 | 104 | 0.030 |
Why?
|
| Phodopus | 1 | 2013 | 7 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2021 | 2667 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2017 | 619 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2013 | 380 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2013 | 5946 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 1889 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2021 | 4016 | 0.030 |
Why?
|
| Substance-Related Disorders | 2 | 2000 | 4418 | 0.030 |
Why?
|
| Boron Compounds | 1 | 2014 | 195 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2004 | 2210 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2024 | 5336 | 0.020 |
Why?
|
| Wound Healing | 1 | 2023 | 2795 | 0.020 |
Why?
|
| Transcription Factors, TFII | 2 | 2002 | 62 | 0.020 |
Why?
|
| Pentacyclic Triterpenes | 1 | 2011 | 36 | 0.020 |
Why?
|
| Microscopy | 1 | 2017 | 900 | 0.020 |
Why?
|
| Limonins | 1 | 2011 | 25 | 0.020 |
Why?
|
| Preleukemia | 1 | 2011 | 34 | 0.020 |
Why?
|
| Transcription Factor TFIID | 2 | 2002 | 150 | 0.020 |
Why?
|
| Genes, jun | 1 | 2011 | 69 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 14645 | 0.020 |
Why?
|
| Evolution, Molecular | 2 | 2011 | 1889 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2017 | 2062 | 0.020 |
Why?
|
| Triterpenes | 1 | 2011 | 78 | 0.020 |
Why?
|
| Cell Movement | 1 | 2023 | 5196 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2013 | 573 | 0.020 |
Why?
|
| DNA Replication | 1 | 2018 | 1428 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 11035 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 1997 | 1181 | 0.020 |
Why?
|
| Flavonols | 1 | 2011 | 84 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2012 | 378 | 0.020 |
Why?
|
| Embryonic Induction | 1 | 2011 | 152 | 0.020 |
Why?
|
| Affinity Labels | 1 | 1990 | 107 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 4887 | 0.020 |
Why?
|
| Genes, Immediate-Early | 1 | 2011 | 102 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 1750 | 0.020 |
Why?
|
| Smoking | 2 | 2011 | 9082 | 0.020 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2010 | 187 | 0.020 |
Why?
|
| Chemistry | 1 | 1990 | 325 | 0.020 |
Why?
|
| Cycloheximide | 1 | 2010 | 339 | 0.020 |
Why?
|
| Organic Chemicals | 1 | 2011 | 211 | 0.020 |
Why?
|
| Microsomes | 1 | 1990 | 252 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 1990 | 483 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2011 | 252 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2010 | 190 | 0.020 |
Why?
|
| Middle Aged | 3 | 2019 | 223083 | 0.020 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2011 | 183 | 0.020 |
Why?
|
| Drosophila | 2 | 2011 | 1506 | 0.020 |
Why?
|
| Molecular Imaging | 1 | 2017 | 822 | 0.020 |
Why?
|
| Smoking Cessation | 1 | 2002 | 2084 | 0.020 |
Why?
|
| Chromosomes, Human, X | 1 | 2012 | 319 | 0.020 |
Why?
|
| Water Supply | 1 | 2011 | 204 | 0.020 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 1996 | 1137 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 11859 | 0.020 |
Why?
|
| Long-Term Potentiation | 1 | 2011 | 290 | 0.020 |
Why?
|
| Luciferases | 1 | 2011 | 712 | 0.020 |
Why?
|
| Incidence | 1 | 2008 | 21513 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2010 | 390 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 18076 | 0.020 |
Why?
|
| NADP | 1 | 1990 | 228 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 1990 | 456 | 0.020 |
Why?
|
| Sirtuin 1 | 1 | 2010 | 247 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2011 | 462 | 0.020 |
Why?
|
| Sexual Behavior | 1 | 1999 | 2192 | 0.020 |
Why?
|
| Alcoholism | 1 | 2000 | 1979 | 0.020 |
Why?
|
| Crystallography | 1 | 2008 | 110 | 0.020 |
Why?
|
| Carbazoles | 1 | 2010 | 229 | 0.020 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 2010 | 306 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2011 | 347 | 0.020 |
Why?
|
| United States | 3 | 2008 | 72920 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 171219 | 0.020 |
Why?
|
| Pesticides | 1 | 2011 | 297 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2018 | 3448 | 0.020 |
Why?
|
| Magnetics | 1 | 2011 | 586 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2023 | 4959 | 0.020 |
Why?
|
| Transcription Factor TFIIIB | 1 | 2007 | 5 | 0.020 |
Why?
|
| Flavonoids | 1 | 2011 | 446 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 636 | 0.020 |
Why?
|
| Education, Medical | 1 | 2000 | 1744 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2009 | 473 | 0.020 |
Why?
|
| Peptide Mapping | 1 | 2008 | 259 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 478 | 0.020 |
Why?
|
| Mutagens | 1 | 2008 | 180 | 0.020 |
Why?
|
| Fasting | 1 | 2013 | 1606 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2008 | 268 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2007 | 199 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 12827 | 0.020 |
Why?
|
| Seasons | 1 | 2013 | 1522 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 4565 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2011 | 588 | 0.020 |
Why?
|
| Risk | 1 | 2019 | 9599 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2009 | 434 | 0.020 |
Why?
|
| Species Specificity | 1 | 2011 | 2406 | 0.020 |
Why?
|
| Metals | 1 | 2011 | 709 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2011 | 582 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2013 | 1242 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2011 | 716 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2007 | 528 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2000 | 3270 | 0.020 |
Why?
|
| Crystallization | 1 | 2007 | 518 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2011 | 719 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2011 | 1205 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2010 | 765 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2010 | 2946 | 0.020 |
Why?
|
| Depression, Chemical | 1 | 2005 | 186 | 0.020 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2011 | 844 | 0.020 |
Why?
|
| Sympathomimetics | 1 | 2005 | 56 | 0.020 |
Why?
|
| Cell Separation | 1 | 2011 | 1718 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2005 | 65 | 0.020 |
Why?
|
| Communication | 1 | 2000 | 3909 | 0.020 |
Why?
|
| Oncogene Proteins v-fos | 1 | 2005 | 15 | 0.020 |
Why?
|
| Sin3 Histone Deacetylase and Corepressor Complex | 1 | 2005 | 19 | 0.020 |
Why?
|
| RNA, Transfer | 1 | 2007 | 284 | 0.020 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2005 | 219 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2005 | 860 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2010 | 2677 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2005 | 295 | 0.010 |
Why?
|
| Prevalence | 1 | 2002 | 15827 | 0.010 |
Why?
|
| Leucine | 1 | 2006 | 547 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2010 | 1393 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 2013 | 2353 | 0.010 |
Why?
|
| Fixatives | 1 | 2004 | 90 | 0.010 |
Why?
|
| Fetal Blood | 1 | 2011 | 1365 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2011 | 1246 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2005 | 287 | 0.010 |
Why?
|
| Cyclin T | 1 | 2003 | 19 | 0.010 |
Why?
|
| Androgens | 1 | 2011 | 1278 | 0.010 |
Why?
|
| HIV Long Terminal Repeat | 1 | 2003 | 86 | 0.010 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2004 | 133 | 0.010 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2003 | 45 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2017 | 3988 | 0.010 |
Why?
|
| Thyroid Hormone Receptors beta | 1 | 2003 | 21 | 0.010 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2003 | 119 | 0.010 |
Why?
|
| Streptavidin | 1 | 2003 | 81 | 0.010 |
Why?
|
| Tetrahymenina | 1 | 2002 | 1 | 0.010 |
Why?
|
| Iodide Peroxidase | 1 | 2005 | 295 | 0.010 |
Why?
|
| Retinoid X Receptors | 1 | 2003 | 91 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 2 | 2005 | 2689 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 3602 | 0.010 |
Why?
|
| Norepinephrine | 1 | 2005 | 898 | 0.010 |
Why?
|
| Disinfectants | 1 | 2004 | 131 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2013 | 2782 | 0.010 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2006 | 659 | 0.010 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2005 | 506 | 0.010 |
Why?
|
| Terminal Repeat Sequences | 1 | 2002 | 70 | 0.010 |
Why?
|
| Templates, Genetic | 1 | 2002 | 188 | 0.010 |
Why?
|
| Heterochromatin | 1 | 2005 | 294 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2009 | 1490 | 0.010 |
Why?
|
| Internationality | 1 | 2008 | 1007 | 0.010 |
Why?
|
| Cyclin E | 1 | 2002 | 155 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 2824 | 0.010 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2003 | 229 | 0.010 |
Why?
|
| E2F Transcription Factors | 1 | 2002 | 269 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2010 | 6208 | 0.010 |
Why?
|
| Receptors, Opioid | 1 | 2002 | 145 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 2430 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2003 | 738 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2002 | 456 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 812 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2005 | 1886 | 0.010 |
Why?
|
| User-Computer Interface | 1 | 2008 | 1407 | 0.010 |
Why?
|
| Cell-Free System | 1 | 2001 | 339 | 0.010 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2006 | 685 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 1805 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2002 | 319 | 0.010 |
Why?
|
| Residence Characteristics | 1 | 2011 | 2116 | 0.010 |
Why?
|
| Education, Medical, Graduate | 1 | 2013 | 2419 | 0.010 |
Why?
|
| Herpes Simplex Virus Protein Vmw65 | 1 | 2000 | 27 | 0.010 |
Why?
|
| Response Elements | 1 | 2002 | 307 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 1430 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2002 | 858 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 4249 | 0.010 |
Why?
|
| Perfusion | 1 | 2005 | 1408 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2013 | 3209 | 0.010 |
Why?
|
| Shaker Superfamily of Potassium Channels | 1 | 2000 | 21 | 0.010 |
Why?
|
| Tetraethylammonium | 1 | 2000 | 55 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 853 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2011 | 3140 | 0.010 |
Why?
|
| Proline | 1 | 2001 | 453 | 0.010 |
Why?
|
| Sp1 Transcription Factor | 1 | 2000 | 143 | 0.010 |
Why?
|
| Odds Ratio | 2 | 2004 | 9657 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2002 | 595 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2013 | 4649 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 6059 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 2000 | 405 | 0.010 |
Why?
|
| Retinoblastoma Protein | 1 | 2002 | 666 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2002 | 41684 | 0.010 |
Why?
|
| Solvents | 1 | 2000 | 299 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2011 | 4044 | 0.010 |
Why?
|
| Pregnancy | 2 | 1990 | 30233 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 9540 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2019 | 81565 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2001 | 1467 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 2001 | 901 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2013 | 4746 | 0.010 |
Why?
|
| Calibration | 1 | 2000 | 813 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2002 | 1060 | 0.010 |
Why?
|
| Bacteria | 1 | 2008 | 2212 | 0.010 |
Why?
|
| Sex Factors | 1 | 2011 | 10614 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2002 | 1179 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 4466 | 0.010 |
Why?
|
| Comorbidity | 1 | 2011 | 10579 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2002 | 1150 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2005 | 2864 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 12976 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2011 | 12775 | 0.010 |
Why?
|
| Piperazines | 1 | 2006 | 2547 | 0.010 |
Why?
|
| Swine | 1 | 2005 | 5986 | 0.010 |
Why?
|
| Adult | 3 | 2013 | 223139 | 0.010 |
Why?
|
| Oocytes | 1 | 2000 | 1168 | 0.010 |
Why?
|
| Risk Factors | 1 | 2002 | 74857 | 0.010 |
Why?
|
| Age Factors | 1 | 2011 | 18386 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 5758 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2006 | 3050 | 0.010 |
Why?
|
| Software | 1 | 2008 | 4463 | 0.010 |
Why?
|
| Risk-Taking | 1 | 1999 | 1021 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 2815 | 0.010 |
Why?
|
| Algorithms | 1 | 2013 | 14066 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2000 | 12061 | 0.000 |
Why?
|
| Curriculum | 1 | 2000 | 3784 | 0.000 |
Why?
|
| Primary Health Care | 1 | 2000 | 4736 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2000 | 39243 | 0.000 |
Why?
|